Premium
Intrathecal baclofen for severe spasticity
Author(s) -
Hankey Graeme J.,
StewartWynne Edward G.,
Perlman David
Publication year - 1986
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1986.tb113877.x
Subject(s) - spasticity , intrathecal , baclofen , medicine , anesthesia , agonist , receptor
The intrathecal administration of baclofen by way of an implanted subcutaneous drug delivery system is described in a patient with a severe spastic paraparesis due to multiple sclerosis. Intrathecally‐administered baclofen is proposed as another therapeutic dimension and adjunct to physical therapy in the management of patients with severe spasticity that is unresponsive to anti‐spasticity agents administered by mouth.